Amgen Inc $122.65

down 0.00


28/7/2014 05:21 PM  |  NASDAQ : AMGN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AMGN Trend Analysis - it has underperformed the S&P 500 by 5%

Partner Headlines

  1. Earnings Scheduled For July 29, 2014

    Benzinga
  2. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  3. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  4. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  5. US Stock Futures Drop Ahead Of Durable Goods Orders Data

    Benzinga
  6. Biotech Enters Reporting Season With Large Caps Central To Sector Performance

    Benzinga
  7. UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 For the Treatment ...

    Benzinga
  8. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  9. Morgan Stanley Issues 2015 'Vintage Values' Stock List

    Benzinga
  10. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  11. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  12. Bind Therapeutics

    IBD
  13. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  14. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  15. Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge 7.5%

    Benzinga
  16. Morning Market Losers

    Benzinga
  17. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  18. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  19. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  20. UPDATE: Morgan Stanley Reiterates On Amgen On New CFO

    Benzinga
  21. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  22. UPDATE: Morgan Stanley Reiterates On Amgen Following AMAGINE-1 Study

    Benzinga
  23. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and AstraZeneca ...

    GuruFocus
  24. Amgen

    IBD
  25. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  26. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  27. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces ...

    Benzinga
  28. Stocks End Six-Day Win Streak As Techs Sell Off

    IBD
  29. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  30. #PreMarket Primer: Wednesday, April 23: Data From China Takes Some Pressure ...

    Benzinga
  31. AMGEN

    IBD
  32. Gilead Soars As Hep C Drug Shatters Views; Amgen Misses

    IBD
  33. Rallying Ahead of Earnings

    FoxBusiness
  34. Nasdaq, S&P 500 On Track For Sixth Straight Gain

    IBD
  35. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  36. Stocks Power Out Early Gains; Allergan Leads Drug-Maker Surge

    IBD
  37. Earnings Scheduled For April 22, 2014

    Benzinga
  38. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  39. Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

    Benzinga
  40. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  41. UPDATE: Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response ...

    Benzinga
  42. Amgen, GSK End Marketing Pact for Osteoporosis Drug

    FoxBusiness
  43. Cholesterol drug meets goal

    IBD
  44. Trial Results Lift Drug Sector

    IBD
  45. Amgen Stock Gets Bump Up On Cholesterol Drug Data

    IBD
  46. Jefferies Raises PT On Amgen, Pricing Pressure Factored IN

    Benzinga
  47. Gilead Adds To Biotech Woes

    IBD
  48. Gilead Sovaldi Scrips Falter As Biotechs Keep Falling

    IBD
  49. New Cholesterol Fighters To Take Center Stage At ACC

    IBD
  50. Market Wrap For March 27: Markets Lower Following Mixed Economic Data

    Benzinga
Trading Center